← Back to Search

Nutrition Therapy

Secretory defect for Gestational Diabetes (HINT-GDM Trial)

N/A
Recruiting
Led By Camille E Powe, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
-Diagnosis of gestational diabetes
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 15 mins - 3 hours
Awards & highlights

HINT-GDM Trial Summary

This trial will study different types of gestational diabetes and how they respond to different types of meals.

Eligible Conditions
  • Gestational Diabetes

HINT-GDM Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

HINT-GDM Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~15 mins - 3 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 15 mins - 3 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Peak blood glucose following test meal (CGM)
Secondary outcome measures
Calorie content of dinner after test meal
Calorie content of lunch after test meal
Carbohydrate content of dinner after test meal
+15 more

HINT-GDM Trial Design

3Treatment groups
Experimental Treatment
Group I: UnclassifiedExperimental Treatment2 Interventions
Participants who cannot be classified as having abnormal insulin secretion or abnormal insulin sensitivity or who have both abnormal insulin sensitivity and abnormal insulin secretion.
Group II: Sensitivity defectExperimental Treatment2 Interventions
Participants defined as having abnormal insulin sensitivity without an absolute defect in insulin secretion.
Group III: Secretory defectExperimental Treatment2 Interventions
Participants defined as having abnormal insulin secretion without a defect in insulin sensitivity.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,918 Previous Clinical Trials
13,192,775 Total Patients Enrolled
Camille E Powe, MDPrincipal InvestigatorMassachusetts General Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are persons aged 40 and up eligible to participate in this clinical experiment?

"This trial seeks applicants aged 18 to 44, while there are 188 clinical trials targeting minors and 889 studies available for seniors."

Answered by AI

What is the maximum enrollment of participants for this clinical trial?

"Affirmative. According to clinicaltrials.gov, this medical experiment which was originally published on February 10th 2020 is currently in search of patients. 60 volunteers must be recruited from two different locations for the trial to continue."

Answered by AI

Is there availability for prospective participants in this trial?

"Affirmative. According to clinicaltrials.gov, the medical trial is still recruiting individuals who meet its criteria. The study was posted on February 10th 2020 and updated lastly on May 7th 2022 with a goal of enrolling 60 patients from two separate sites."

Answered by AI

To what demographic would this clinical trial be most advantageous?

"This medical study is recruiting 60 volunteers aged 18-44 who already have diabetes mellitus. Additionally, they must meet the requirement of being diagnosed with gestational diabetes."

Answered by AI
~12 spots leftby Mar 2025